Glukokortikoidinduceret diabetes og risikofaktorer under højdosisbehandling

Translated title of the contribution: Glucocorticoid-induced diabetes and risk factors during high-dose therapy

Dustin Andersen Patel, Peter Lommer Kristensen, Ulrik Pedersen-Bjergaard, Helga Holm Schultz

Research output: Contribution to journalJournal articleResearchpeer-review

4 Citations (Scopus)

Abstract

This review describes the cumulative incidence (CI) and risk factors of glucocorticoid (GC)-induced diabetes in patients commencing high-dose GC therapy: ≥ 30 mg prednisolone/day. Finally, methods of screening are discussed. In 13 studies, the CI of GC-induced diabetes ranges 12-65%, but with the current diagnostic criteria the CI is assessed to be 30-50%. Risk factors may include high age and high levels of BMI and glycated haemoglobin, respectively, before GC therapy. It is important to acknowledge, that hyperglycaemia in GC therapy is more prevalent postprandially, and screening should be planned accordingly.

Translated title of the contributionGlucocorticoid-induced diabetes and risk factors during high-dose therapy
Original languageDanish
Article numberV06170454
JournalUgeskrift for Laeger
Volume180
Number of pages6
ISSN0041-5782
Publication statusPublished - 2018

Cite this